Pictet Asset Management (UK)’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Pictet Asset Management (UK)’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-33,710	Closed	-$3.64M	–	1235
2020 Q1	$3.64M	Buy	33,710 +8,200	+32%	+$942K	0.01%	724
2019 Q4	$2.97M	Buy	+25,510	New	+$2.95M	0.01%	870
2018 Q2	–	Sell	-19,436	Closed	-$1.57M	–	928
2018 Q1	$1.57M	Buy	19,436 +100	+0.5%	+$8.08K	﹤0.01%	808
2017 Q4	$1.52M	Buy	+19,336	New	+$1.61M	﹤0.01%	815
2017 Q3	–	Sell	-19,800	Closed	-$2.25M	–	918
2017 Q2	$2.25M	Buy	19,800 +2,200	+13%	+$246K	0.01%	770
2017 Q1	$1.76M	Buy	+17,600	New	+$1.88M	0.01%	784
2015 Q4	–	Sell	-16,504	Closed	-$1.48M	–	896
2015 Q3	$1.48M	Sell	16,504 -2,907	-15%	-$307K	0.01%	749
2015 Q2	$2.38M	Buy	+19,411	New	+$2.04M	0.01%	731

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pictet Asset Management (UK)'s CBPO Position: Q2 2020 in Review

Pictet Asset Management (UK) sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2020, closing a stake of 33,710 shares — an estimated $3.64M sold.

Pictet Asset Management (UK) first reported a position in CBPO in Q2 2015 and held it in 8 quarters. The position peaked at $3.64M in Q1 2020. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2020.

Pictet Asset Management (UK) reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2020 after selling out during the quarter.
Pictet Asset Management (UK) sold 33,710 China Biologic Products Holdings, Inc. shares in Q2 2020, an estimated $3.64M.
Pictet Asset Management (UK) first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 8 quarters.
Pictet Asset Management (UK)'s China Biologic Products Holdings, Inc. position peaked at $3.64M in Q1 2020.
91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2020.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2020, filed 13 Aug 2020.